• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢噻肟:对革兰氏阳性球菌引起的下呼吸道感染的疗效及耐受性

Cefotaxime: efficacy and tolerance in lower respiratory tract infections caused by gram-positive cocci.

作者信息

Lode H, Glatzel P D

出版信息

Infection. 1985;13 Suppl 1:S25-7. doi: 10.1007/BF01644213.

DOI:10.1007/BF01644213
PMID:4055050
Abstract

Cefotaxime is an effective antibiotic in lower respiratory tract infection caused by streptococci and staphylococci. There is a limited tendency to superinfections with Pseudomonas aeruginosa (1.5%) and there is a low incidence of side-effects. It is questionable whether there is really an urgent need for cefotaxime in gram-positive lower respiratory tract infections.

摘要

头孢噻肟是治疗由链球菌和葡萄球菌引起的下呼吸道感染的有效抗生素。铜绿假单胞菌二重感染的倾向有限(1.5%),且副作用发生率较低。对于革兰氏阳性菌引起的下呼吸道感染,是否真的急需使用头孢噻肟值得怀疑。

相似文献

1
Cefotaxime: efficacy and tolerance in lower respiratory tract infections caused by gram-positive cocci.头孢噻肟:对革兰氏阳性球菌引起的下呼吸道感染的疗效及耐受性
Infection. 1985;13 Suppl 1:S25-7. doi: 10.1007/BF01644213.
2
Cefotaxime in the treatment of lower respiratory tract infections.头孢噻肟治疗下呼吸道感染
Int J Clin Pharmacol Ther Toxicol. 1983 Dec;21(12):605-10.
3
Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli.用头孢噻肟治疗多重耐药革兰氏阴性杆菌引起的严重感染。
Scand J Infect Dis. 1982;14(1):57-60. doi: 10.3109/inf.1982.14.issue-1.11.
4
An overview of cefotaxime therapy in infections caused by gram-positive pathogens.头孢噻肟治疗革兰氏阳性病原体引起感染的概述。
Infection. 1985;13 Suppl 1:S3-6. doi: 10.1007/BF01644208.
5
A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
J Chemother. 1995 Apr;7(2):153-6. doi: 10.1179/joc.1995.7.2.153.
6
Clinical experience of cefotaxime in infections caused by gram-positive pathogens.头孢噻肟治疗革兰氏阳性病原体所致感染的临床经验
Infection. 1985;13 Suppl 1:S112-4. doi: 10.1007/BF01644230.
7
A review of the use of cefotaxime in the treatment of skin and skin structure infections, with special reference to gram-positive pathogens.头孢噻肟在治疗皮肤及皮肤结构感染中的应用综述,特别提及革兰氏阳性病原体。
Infection. 1985;13 Suppl 1:S46-9. doi: 10.1007/BF01644218.
8
Therapy of lower respiratory tract infections: a comparison of ceftriaxone and cefotaxime.下呼吸道感染的治疗:头孢曲松与头孢噻肟的比较
Chemotherapy. 1989;35 Suppl 2:33-40. doi: 10.1159/000238737.
9
A comparison of cefotaxime and cefoperazone in respiratory tract infections.头孢噻肟与头孢哌酮治疗呼吸道感染的比较。
J Antimicrob Chemother. 1984 Sep;14 Suppl B:301-6. doi: 10.1093/jac/14.suppl_b.301.
10
Cefotaxime in the treatment of chronic osteomyelitis caused by gram-negative bacilli.
J Antimicrob Chemother. 1990 Sep;26 Suppl A:45-52. doi: 10.1093/jac/26.suppl_a.45.

引用本文的文献

1
Cefotaxime. An update of its pharmacology and therapeutic use.头孢噻肟。其药理学与治疗应用的最新进展。
Drugs. 1990 Oct;40(4):608-51. doi: 10.2165/00003495-199040040-00008.

本文引用的文献

1
Cefotaxime in the treatment of lower respiratory tract infections.头孢噻肟治疗下呼吸道感染
Int J Clin Pharmacol Ther Toxicol. 1983 Dec;21(12):605-10.
2
Prospective randomized comparative studies of mezlocillin/cefotaxime vs. gentamicin/cefoxitin.
J Antimicrob Chemother. 1983 May;11 Suppl C:91-5. doi: 10.1093/jac/11.suppl_c.91.
3
The use of cefotaxime in pneumology.头孢噻肟在肺病学中的应用。
Acta Med Port. 1983 Feb;4(2):87-90.
4
Clinical trials of cefotaxime for the treatment of bacterial infections of the lower respiratory tract.头孢噻肟治疗下呼吸道细菌感染的临床试验。
Rev Infect Dis. 1982 Sep-Oct;4 Suppl:S421-31. doi: 10.1093/clinids/4.supplement_2.s421.
5
Cefotaxime in the management of acute lower respiratory tract infection.头孢噻肟用于治疗急性下呼吸道感染
Ir Med J. 1982 May;75(5 Suppl):6-7.
6
Clinical efficacy of cefotaxime in serious infections.头孢噻肟在严重感染中的临床疗效。
Antimicrob Agents Chemother. 1982 Jan;21(1):119-24. doi: 10.1128/AAC.21.1.119.
7
Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections.头孢噻肟治疗下呼吸道感染的临床评估。
Antimicrob Agents Chemother. 1982 Feb;21(2):327-33. doi: 10.1128/AAC.21.2.327.
8
Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms.
Am J Med. 1981 Sep;71(3):435-42. doi: 10.1016/0002-9343(81)90173-x.
9
Cefotaxime therapy in children with serious infections associated with reduced host defense mechanisms.头孢噻肟治疗伴有宿主防御机制降低的严重感染患儿。
J Antimicrob Chemother. 1980 Sep;6 Suppl A:249-53. doi: 10.1093/jac/6.suppl_a.249.
10
Cefotaxime in the treatment of severe paediatric infections.头孢噻肟治疗小儿严重感染
J Antimicrob Chemother. 1980 Sep;6 Suppl A:243-8. doi: 10.1093/jac/6.suppl_a.243.